ClinicalTrials.Veeva

Menu

Reperfusion With Cooling in Cerebral Acute Ischemia (ReCCLAIM)

Emory University logo

Emory University

Status and phase

Completed
Phase 1

Conditions

Stroke, Acute

Treatments

Device: Zoll- Coolgaurd 3000

Study type

Interventional

Funder types

Other

Identifiers

NCT01585597
IRB00056889
MSNC 01 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to determine whether reducing a patients body temperature (mild hypothermia of 33 degrees Centigrade) will significantly reduce the risk of brain injury (notably reperfusion injury and hemorrhagic conversion) in patients that have suffered a significant interruption of blood flow to an area of brain (occlusion of large proximal cerebral artery) and have undergone successful removal of that interruption (revascularization).

Enrollment

20 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-85 years old
  • Symptoms consistent with an ischemic stroke with a large vessel occlusion (MCA, ICA-terminus) as determined by vascular imaging
  • ASPECTS score of 5-7 on non-contrast CT of the brain
  • Ability to undergo endovascular reperfusion therapy
  • Must have no contraindications to general anesthesia
  • A pre-treatment modified Rankin Score of 0 or 1
  • Arterial puncture performed under 8 hours from symptom onset or last seen normal
  • Immediate post reperfusion CT scan shows no hemorrhage

Exclusion criteria

  • Bleeding diathesis with a platelet count < 50,000 or INR > 1.5
  • Involved in another clinical trial
  • History of dementia
  • End stage renal disease on hemodialysis
  • History of ventricular dysrhythmias
  • Life threatening medical condition precluding survival under 6 months
  • Presence of an IVC filter
  • Contrast dye allergy with history of anaphylaxis

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Mild Hypothermia
Experimental group
Description:
Reduction of body temperature to 34 degrees centigrade. This will be accomplished using the Zoll Coolguard .
Treatment:
Device: Zoll- Coolgaurd 3000

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems